EMERYVILLE, Calif. (AP) — EMERYVILLE, Calif. (AP) — Dynavax Technologies Corp. (DVAX) on Thursday reported third-quarter net income of $17.6 million. On a per-share basis, the Emeryville, ...
engages in the discovery and development of innovative therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by ...
Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced its Board of Directors has authorized ...
Whether you're looking for adventure, work opportunities, new scenery or better weather conditions, California cities represent a special, sunny place in the popular imagination. But before packing ...
Hepatitis B adult vaccine market expected to expand to a peak of over $900 million by 2030, with HEPLISAV-B expected to achieve at least 60% estimated total market share "We are confident that the ...
Another Trump term could spur Europe’s efforts to stand on its own, but it is far from clear its leaders will seize the moment this time. By Steven Erlanger Beijing is expecting more ...